Wall Street brokerages expect Agilent Technologies, Inc. (NYSE:A) to post earnings of $0.63 per share for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Agilent Technologies’ earnings. The highest EPS estimate is $0.67 and the lowest is $0.61. Agilent Technologies reported earnings per share of $0.59 during the same quarter last year, which would indicate a positive year over year growth rate of 6.8%. The firm is scheduled to report its next earnings report on Tuesday, November 21st.

On average, analysts expect that Agilent Technologies will report full-year earnings of $2.32 per share for the current fiscal year, with EPS estimates ranging from $2.30 to $2.36. For the next financial year, analysts forecast that the business will report earnings of $2.59 per share, with EPS estimates ranging from $2.51 to $2.68. Zacks’ EPS calculations are an average based on a survey of analysts that cover Agilent Technologies.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 earnings per share.

A has been the topic of a number of recent analyst reports. Deutsche Bank AG reaffirmed a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research note on Thursday, June 22nd. Morgan Stanley increased their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 24th. Jefferies Group LLC reissued a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 9th. BTIG Research increased their price objective on shares of Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research report on Wednesday, May 24th. Finally, BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Agilent Technologies has a consensus rating of “Buy” and an average target price of $63.91.

COPYRIGHT VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/09/17/0-63-earnings-per-share-expected-for-agilent-technologies-inc-a-this-quarter.html.

In related news, insider Mark Doak sold 12,421 shares of the firm’s stock in a transaction on Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the sale, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 155,165 shares of company stock valued at $9,768,409.

Hedge funds have recently made changes to their positions in the business. Balentine LLC grew its holdings in Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after acquiring an additional 50 shares in the last quarter. Sun Life Financial INC grew its holdings in Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after acquiring an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC grew its holdings in Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after acquiring an additional 1,200 shares in the last quarter. Parallel Advisors LLC grew its holdings in Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after acquiring an additional 131 shares in the last quarter. Finally, Trust Co. of Vermont grew its holdings in Agilent Technologies by 1.8% during the 2nd quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after acquiring an additional 50 shares in the last quarter.

Agilent Technologies (NYSE A) opened at 65.96 on Friday. The firm has a 50 day moving average of $62.40 and a 200 day moving average of $58.01. Agilent Technologies has a 1-year low of $42.92 and a 1-year high of $66.42. The firm has a market cap of $21.23 billion, a P/E ratio of 34.02 and a beta of 1.30.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.